Published Date:2024-05-13 Original Link:https://www.onenessbio.com/en/news_detail285_4.htm No 1 Date of announcement 2024/05/13 Time of announcement 16:53:53 Subject The Board of Directors approved the amendment of 2023 Restricted Stock Awards Issuance Rules To which item it meets paragraph 11 Date of events 2024/05/13 Statement Date of occurrence of the event: 2024/05/13 Date of the original announcement and reporting:...Read More
Published Date:2024-05-13 Original Link:https://www.onenessbio.com/en/news_detail287_3.htm No 3 Date of announcement 2024/05/13 Time of announcement 17:09:59 Subject The Company’s 2024Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2024/05/13 Statement Date of the board of directors submitted or approved: 2024/05/13 Date of the audit...Read More
Published Date:2024-05-13 Original Link:https://www.onenessbio.com/en/news_detail286_3.htm No 2 Date of announcement 2024/05/13 Time of announcement 16:59:51 Subject The board of directors of the Company approved removal of the noncompete clause for managers. To which item it meets paragraph 21 Date of events 2024/05/13 Statement Date of the board of directors resolution: 2024/05/13 Name and title of the...Read More
Published Date:2024-05-09 Original Link:https://www.onenessbio.com/en/news_detail284_4.htm No 1 Date of announcement 2024/05/09 Time of announcement 17:52:36 Subject S.C. injection formulation of FB825 has been agreed by US FDA to proceed with Phase 2 clinical trial to treat moderate-to-severe atopic dermatitis. To which item it meets paragraph 10 Date of events 2024/05/09 Statement Date of occurrence of the...Read More
Published Date:2024-05-03 Original Link:https://www.onenessbio.com/en/news_detail282_4.htm No 1 Date of announcement 2024/05/03 Time of announcement 17:15:55 Subject Announcement the Company’s board of directors meeting date of the First Quarter of 2024 Consolidated Financial Reports To which item it meets paragraph 31 Date of events 2024/05/03 Statement Date of a notice of the board of directors meeting is...Read More
Published Date:2024-05-02 Original Link:https://www.onenessbio.com/en/news_detail281_4.htm No 1 Date of announcement 2024/05/02 Time of announcement 17:53:51 Subject Oneness Biotech Co., Ltd. receives a Japanese patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/05/02 Statement Date of occurrence of the event: 2024/05/02...Read More
Published Date:2024-04-22 Original Link:https://www.onenessbio.com/en/news_detail280_4.htm No 1 Date of announcement 2024/04/22 Time of announcement 18:16:38 Subject Subcutaneous injection formulation of FB825 to treat moderate-to-severe atopic dermatitis was greenlighted by TFDA to proceed with a Ph2 study To which item it meets paragraph 10 Date of events 2024/04/22 Statement Date of occurrence of the event:2024/04/22 New drug...Read More
Published Date:2024-03-29 Original Link:https://www.onenessbio.com/en/news_detail279_4.htm No 1 Date of announcement 2024/03/29 Time of announcement 18:08:07 Subject Submission of a phase II clinical trial protocol to Taiwan FDA for subcutaneous injection formulation of FB825 in patients with moderate-to-severe atopic dermatitis To which item it meets paragraph 10 Date of events 2024/03/29 Statement Date of occurrence of the...Read More
Published Date:2024-03-22 Original Link:https://www.onenessbio.com/en/news_detail278_4.htm No 1 Date of announcement 2024/03/22 Time of announcement 17:16:28 Subject Oneness announces the information about the investor’s conference of 2024 Q1. To which item it meets paragraph 12 Date of events 2024/03/29 Statement Date of institutional investor conference:2024/03/29 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More
